Article ID Journal Published Year Pages File Type
3284573 Clinical Gastroenterology and Hepatology 2008 5 Pages PDF
Abstract
In patients with severe corticosteroid-refractory ulcerative colitis who fail treatment with either cyclosporine or infliximab, remission rates using acute salvage therapy by crossing over to the other drug occur in approximately one third of patients and have limited duration. Serious adverse events occurred in 16%, including 1 death, suggesting that the risks of acute salvage therapy may outweigh the benefits.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , ,